{"id":10191,"date":"2026-05-18T10:45:03","date_gmt":"2026-05-18T17:45:03","guid":{"rendered":"https:\/\/keck.usc.edu\/news\/?p=10191"},"modified":"2026-05-18T10:46:28","modified_gmt":"2026-05-18T17:46:28","slug":"inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening","status":"publish","type":"post","link":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/","title":{"rendered":"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening"},"content":{"rendered":"\n \n \n\n\n\n\n\n\n\n
\n\n \n
\n \n
\n\n \n Campus News<\/span>\n\n\n\n<\/div>\n \n \n
\n\n \n

Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening<\/h1>\n\n\n<\/div>\n \n \n
\n\n \n

The USC Roski Eye Institute ophthalmologist is filling gaps in the field\u2019s understanding of early detection efforts.<\/p>\n\n\n\n<\/div>\n \n

\n Wayne Lewis<\/span>\n \n May 18, 2026<\/span>\n <\/div>\n \n \n
\n\n \n
<\/path><\/svg><\/span><\/a><\/path><\/svg><\/span><\/a><\/path><\/svg><\/span><\/a><\/path><\/path><\/path><\/svg><\/span><\/a><\/path><\/svg><\/span><\/a><\/path><\/path><\/g><\/svg><\/span><\/a><\/svg><\/span><\/a><\/div>
<\/div><\/div>\n\n\n<\/div>\n \n <\/div>\n\n \n
\n\n \n \n \n
\n \n \n \n \n \n\n \n
Kyle Bolo (Photo by Ricardo Carrasco III)<\/figcaption>\n <\/figure>\n \n \n \n\n<\/div>\n \n\n <\/div><\/div>\n\n\n\n\n \n \n\n\n\n\n\n\n\n
\n\n \n
\n \n
\n\n \n

For glaucoma specialist Kyle Bolo, MD<\/a>, his research mission starts with patients he sees in the clinic every day. All too often, they\u2019ve already experienced some vision loss from an irreversible disease of the optic nerve that, without intervention, can lead to blindness.<\/p>\n

\u201cGlaucoma is sort of a silent disease,\u201d said Bolo, an assistant professor of clinical ophthalmology at the Keck School of Medicine of USC<\/a>. \u201cA lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there\u2019s less to save, and it\u2019s harder to save what remains. That strongly motivates my research.\u201d<\/p>\n

He\u2019s working toward a day when early detection makes advanced glaucoma an unlikely diagnosis, with support from the American Glaucoma Society, industry collaborators at Zeiss and National Institutes of Health funding through the Southern California Clinical and Translational Science Institute. Bolo and his teammates at the USC Roski Eye Institute<\/a> are using machine learning algorithms to comb through long-term data about current glaucoma screening practices. They aim to bring light to unanswered questions about the effectiveness of current screening in improving patient outcomes.<\/p>\n

\u201cThere are some gaps in our literature,\u201d Bolo said. \u201cScreening has a long history in glaucoma, but the health outcomes and any potential for unintended effects have never been studied thoroughly. We\u2019re trying to analyze large amounts of data to make conclusions about the practice of screening that can be applied broadly.\u201d<\/p>\n

An opportunity to shed new light on glaucoma screening<\/strong><\/h2>\n

The attempt to preserve people\u2019s vision through widespread screening comes with its own risks. False positives lead to overtreatment, unnecessarily exposing some patients to side effects from medicine or surgery. Even if a specialist determines a patient does not have glaucoma, the referral itself can create turmoil.<\/p>\n

\u201cSometimes patients come to us very scared,\u201d Bolo said. \u201cOverdiagnosis itself can be emotionally burdensome.\u201d<\/p>\n

The few studies evaluating glaucoma screening have tended to be short-term and limited in scope. This is due in part to the difficulties of following patient outcomes after screenings come up negative. Even patients who test positive are difficult to follow after initial treatment.<\/p>\n

Bolo and his colleagues are able to investigate rich longitudinal data through a partnership with the Los\u00a0Angeles County Department of Public Health<\/a>\u2019s ophthalmology department. Over more than a decade, 85,000 diabetes patients have been tested for glaucoma alongside complications of diabetes that can affect vision. This trove of data brings power to the researchers\u2019 findings. It also calls for the use of advanced statistical techniques and machine learning.<\/p>\n

(Regarding patient privacy, Bolo emphasizes that all data is stripped of patient identifiers, that machine learning is used solely for complex statistical analysis, and that data is never exposed or used to train public algorithms.)<\/p>\n

Patients who screened positive for glaucoma in the L.A. County program underwent diagnostic evaluation with eyecare providers. The judgments of those experts will play a key role in Bolo\u2019s analysis.<\/p>\n

\u201cBy having glaucoma specialists review a portion of the diagnostic tests and label which evaluations correspond with true glaucoma, we can develop statistical models that we can apply to the whole dataset to determine, with a high degree of certainty, which patients have glaucoma,\u201d he said. \u201cThat allows us to avoid the immense task of reviewing thousands and thousands of cases \u2014 a foundational step to do this large, data science-driven research into whether screening works.\u201d<\/p>\n

Bringing the engineer\u2019s perspective to biomedical science<\/strong><\/h2>\n

It only makes sense that Bolo pursues research at the intersection of medicine and computer science. Although raised by two physicians who encouraged interest in medicine, he majored in math as an undergraduate.<\/p>\n

\u201cMedicine was always in the background of my life, but as far back as I can remember, I\u2019ve very much had an engineering mindset,\u201d he said. \u201cI loved to tinker.\u201d<\/p>\n

His first job channeled his enthusiasm for computer science with the electronic health record company Epic Systems. This proved to be a formative experience that influenced his calling.<\/p>\n

\u201cI was exposed to ideas about how to organize patient data at Epic that inform how our team handles complex glaucoma data for reliable data-driven science,\u201d he said. \u201cMoving into medicine seemed like a way to take that engineering mindset and make an impact that helps people directly.\u201d<\/p>\n

After earning his medical degree at Columbia University, he became a resident at the Keck School of Medicine, where he conducted research with Ben Xu, MD, PhD<\/a>, associate professor of ophthalmology, clinical scholar and chief of the USC Roski Eye Institute\u2019s Glaucoma Service. Returning after his fellowship training to become a USC faculty member seemed like the natural choice for Bolo.<\/p>\n

\u201cBen is a very effective mentor, and the quality of mentorship at USC overall was a huge draw for me,\u201d he said. \u201cThere\u2019s a group of faculty here that give me a good trajectory to follow as a clinician-scientist.\u201d<\/p>\n

Bolo continues to partner with Xu, director of data science and AI at the USC Roski Eye Institute, on a larger slate of high-tech investigations. In collaboration with faculty from the USC Viterbi School of Engineering<\/a>, they explore how telemedicine and artificial intelligence<\/a> might be deployed to improve glaucoma care.<\/p>\n

\u201cIf done cautiously, there\u2019s just so much potential for AI to be applied beneficially in our everyday clinical workflows,\u201d Bolo said.<\/p>\n

His future ambitions include launching trials that compare outcomes between patients screened for glaucoma and those who aren\u2019t. He wants to answer open questions about how screening compares to standard care, whether it actually affects the early detection of disease, and whether it\u2019s beneficial to patients in the long run.<\/p>\n

\u201cFiguring out how to make screening effective starts with understanding how it\u2019s working now,\u201d Bolo said. \u201cI\u2019m open-minded \u2014 I have to be as a scientist \u2014 but I hope we find that screening is effective, for the sake of patients.\u201d<\/p>\n

Learn more about research at the Keck School of Medicine<\/a>.<\/strong><\/em><\/p>\n\n\n\n<\/div>\n <\/div>\n\n\n <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":176,"featured_media":10193,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[7],"tags":[476,627,169,20,520],"class_list":["post-10191","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-campus-news","tag-brain-health","tag-department-of-ophthalmology","tag-latest","tag-research","tag-usc-roski-eye-institute"],"acf":[],"yoast_head":"\nInspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening<\/title>\n<meta name=\"description\" content=\"For glaucoma specialist Kyle Bolo, MD, his research mission starts with patients he sees in the clinic every day. All too often, they\u2019ve already experienced some vision loss from an irreversible disease of the optic nerve that, without intervention, can lead to blindness.\u201cGlaucoma is sort of a silent disease,\u201d said Bolo, an assistant professor of clinical ophthalmology at the Keck School of Medicine of USC. \u201cA lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there\u2019s less to save, and it\u2019s harder to save what remains. That strongly motivates my research.\u201dHe\u2019s working toward a day when early detection makes advanced glaucoma an unlikely diagnosis, with support from the American Glaucoma Society, industry collaborators at Zeiss and National Institutes of Health funding through the Southern California Clinical and Translational Science Institute. Bolo and his teammates at the USC Roski Eye Institute are using machine learning algorithms to comb through long-term data about current glaucoma screening practices. They aim to bring light to unanswered questions about the effectiveness of current screening in improving patient outcomes.\u201cThere are some gaps in our literature,\u201d Bolo said. \u201cScreening has a long history in glaucoma, but the health outcomes and any potential for unintended effects have never been studied thoroughly. We\u2019re trying to analyze large amounts of data to make conclusions about the practice of screening that can be applied broadly.\u201d\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening\" \/>\n<meta property=\"og:description\" content=\"For glaucoma specialist Kyle Bolo, MD, his research mission starts with patients he sees in the clinic every day. All too often, they\u2019ve already experienced some vision loss from an irreversible disease of the optic nerve that, without intervention, can lead to blindness.\u201cGlaucoma is sort of a silent disease,\u201d said Bolo, an assistant professor of clinical ophthalmology at the Keck School of Medicine of USC. \u201cA lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there\u2019s less to save, and it\u2019s harder to save what remains. That strongly motivates my research.\u201dHe\u2019s working toward a day when early detection makes advanced glaucoma an unlikely diagnosis, with support from the American Glaucoma Society, industry collaborators at Zeiss and National Institutes of Health funding through the Southern California Clinical and Translational Science Institute. Bolo and his teammates at the USC Roski Eye Institute are using machine learning algorithms to comb through long-term data about current glaucoma screening practices. They aim to bring light to unanswered questions about the effectiveness of current screening in improving patient outcomes.\u201cThere are some gaps in our literature,\u201d Bolo said. \u201cScreening has a long history in glaucoma, but the health outcomes and any potential for unintended effects have never been studied thoroughly. We\u2019re trying to analyze large amounts of data to make conclusions about the practice of screening that can be applied broadly.\u201d\" \/>\n<meta property=\"og:url\" content=\"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KECKschoolUSC\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-18T17:45:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-18T17:46:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2026\/05\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lytal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KeckSchool_USC\" \/>\n<meta name=\"twitter:site\" content=\"@KeckSchool_USC\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/\"},\"author\":{\"name\":\"lytal\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/person\\\/6cfb16bad28bfa5e488ddb7cfe47cd3d\"},\"headline\":\"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening\",\"datePublished\":\"2026-05-18T17:45:03+00:00\",\"dateModified\":\"2026-05-18T17:46:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/\"},\"wordCount\":12,\"publisher\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2026\\\/05\\\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg\",\"keywords\":[\"Brain Health\",\"Department of Ophthalmology\",\"Latest\",\"Research\",\"USC Roski Eye Institute\"],\"articleSection\":[\"Campus News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/\",\"name\":\"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2026\\\/05\\\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg\",\"datePublished\":\"2026-05-18T17:45:03+00:00\",\"dateModified\":\"2026-05-18T17:46:28+00:00\",\"description\":\"For glaucoma specialist Kyle Bolo, MD, his research mission starts with patients he sees in the clinic every day. All too often, they\u2019ve already experienced some vision loss from an irreversible disease of the optic nerve that, without intervention, can lead to blindness.\u201cGlaucoma is sort of a silent disease,\u201d said Bolo, an assistant professor of clinical ophthalmology at the Keck School of Medicine of USC. \u201cA lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there\u2019s less to save, and it\u2019s harder to save what remains. That strongly motivates my research.\u201dHe\u2019s working toward a day when early detection makes advanced glaucoma an unlikely diagnosis, with support from the American Glaucoma Society, industry collaborators at Zeiss and National Institutes of Health funding through the Southern California Clinical and Translational Science Institute. Bolo and his teammates at the USC Roski Eye Institute are using machine learning algorithms to comb through long-term data about current glaucoma screening practices. They aim to bring light to unanswered questions about the effectiveness of current screening in improving patient outcomes.\u201cThere are some gaps in our literature,\u201d Bolo said. \u201cScreening has a long history in glaucoma, but the health outcomes and any potential for unintended effects have never been studied thoroughly. We\u2019re trying to analyze large amounts of data to make conclusions about the practice of screening that can be applied broadly.\u201d\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/#primaryimage\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2026\\\/05\\\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2026\\\/05\\\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg\",\"width\":2560,\"height\":1440,\"caption\":\"Kyle Bolo (Photo by Ricardo Carrasco III)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#organization\",\"name\":\"Keck School of Medicine of USC\",\"alternateName\":\"Keck School of Medicine\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/keck-school-of-medicine-logo-696-square.jpg\",\"contentUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/keck-school-of-medicine-logo-696-square.jpg\",\"width\":696,\"height\":696,\"caption\":\"Keck School of Medicine of USC\"},\"image\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/KECKschoolUSC\\\/\",\"https:\\\/\\\/x.com\\\/KeckSchool_USC\",\"https:\\\/\\\/www.linkedin.com\\\/school\\\/keckschoolusc\\\/\",\"https:\\\/\\\/www.instagram.com\\\/KeckSchoolUSC\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCpL1E1W5ZTfkc5iihwLSFEA\",\"https:\\\/\\\/www.tiktok.com\\\/@keckschoolusc\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/person\\\/6cfb16bad28bfa5e488ddb7cfe47cd3d\",\"name\":\"lytal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/22ea1d436dde113885aec63d42e72b924f771e6f26d86979609313d84845e184?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/22ea1d436dde113885aec63d42e72b924f771e6f26d86979609313d84845e184?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/22ea1d436dde113885aec63d42e72b924f771e6f26d86979609313d84845e184?s=96&d=mm&r=g\",\"caption\":\"lytal\"},\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/author\\\/clytal\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening","description":"For glaucoma specialist Kyle Bolo, MD, his research mission starts with patients he sees in the clinic every day. All too often, they\u2019ve already experienced some vision loss from an irreversible disease of the optic nerve that, without intervention, can lead to blindness.\u201cGlaucoma is sort of a silent disease,\u201d said Bolo, an assistant professor of clinical ophthalmology at the Keck School of Medicine of USC. \u201cA lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there\u2019s less to save, and it\u2019s harder to save what remains. That strongly motivates my research.\u201dHe\u2019s working toward a day when early detection makes advanced glaucoma an unlikely diagnosis, with support from the American Glaucoma Society, industry collaborators at Zeiss and National Institutes of Health funding through the Southern California Clinical and Translational Science Institute. Bolo and his teammates at the USC Roski Eye Institute are using machine learning algorithms to comb through long-term data about current glaucoma screening practices. They aim to bring light to unanswered questions about the effectiveness of current screening in improving patient outcomes.\u201cThere are some gaps in our literature,\u201d Bolo said. \u201cScreening has a long history in glaucoma, but the health outcomes and any potential for unintended effects have never been studied thoroughly. We\u2019re trying to analyze large amounts of data to make conclusions about the practice of screening that can be applied broadly.\u201d","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/","og_locale":"en_US","og_type":"article","og_title":"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening","og_description":"For glaucoma specialist Kyle Bolo, MD, his research mission starts with patients he sees in the clinic every day. All too often, they\u2019ve already experienced some vision loss from an irreversible disease of the optic nerve that, without intervention, can lead to blindness.\u201cGlaucoma is sort of a silent disease,\u201d said Bolo, an assistant professor of clinical ophthalmology at the Keck School of Medicine of USC. \u201cA lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there\u2019s less to save, and it\u2019s harder to save what remains. That strongly motivates my research.\u201dHe\u2019s working toward a day when early detection makes advanced glaucoma an unlikely diagnosis, with support from the American Glaucoma Society, industry collaborators at Zeiss and National Institutes of Health funding through the Southern California Clinical and Translational Science Institute. Bolo and his teammates at the USC Roski Eye Institute are using machine learning algorithms to comb through long-term data about current glaucoma screening practices. They aim to bring light to unanswered questions about the effectiveness of current screening in improving patient outcomes.\u201cThere are some gaps in our literature,\u201d Bolo said. \u201cScreening has a long history in glaucoma, but the health outcomes and any potential for unintended effects have never been studied thoroughly. We\u2019re trying to analyze large amounts of data to make conclusions about the practice of screening that can be applied broadly.\u201d","og_url":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/KECKschoolUSC\/","article_published_time":"2026-05-18T17:45:03+00:00","article_modified_time":"2026-05-18T17:46:28+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2026\/05\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg","type":"image\/jpeg"}],"author":"lytal","twitter_card":"summary_large_image","twitter_creator":"@KeckSchool_USC","twitter_site":"@KeckSchool_USC","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/#article","isPartOf":{"@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/"},"author":{"name":"lytal","@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/person\/6cfb16bad28bfa5e488ddb7cfe47cd3d"},"headline":"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening","datePublished":"2026-05-18T17:45:03+00:00","dateModified":"2026-05-18T17:46:28+00:00","mainEntityOfPage":{"@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/"},"wordCount":12,"publisher":{"@id":"https:\/\/keck.usc.edu\/news\/#organization"},"image":{"@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/#primaryimage"},"thumbnailUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2026\/05\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg","keywords":["Brain Health","Department of Ophthalmology","Latest","Research","USC Roski Eye Institute"],"articleSection":["Campus News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/","url":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/","name":"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening","isPartOf":{"@id":"https:\/\/keck.usc.edu\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/#primaryimage"},"image":{"@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/#primaryimage"},"thumbnailUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2026\/05\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg","datePublished":"2026-05-18T17:45:03+00:00","dateModified":"2026-05-18T17:46:28+00:00","description":"For glaucoma specialist Kyle Bolo, MD, his research mission starts with patients he sees in the clinic every day. All too often, they\u2019ve already experienced some vision loss from an irreversible disease of the optic nerve that, without intervention, can lead to blindness.\u201cGlaucoma is sort of a silent disease,\u201d said Bolo, an assistant professor of clinical ophthalmology at the Keck School of Medicine of USC. \u201cA lot of patients have been either undertreated or not treated at all, and they come in with advanced disease. That always hurts, because I can do everything in my power to help them maintain what they have, but there\u2019s less to save, and it\u2019s harder to save what remains. That strongly motivates my research.\u201dHe\u2019s working toward a day when early detection makes advanced glaucoma an unlikely diagnosis, with support from the American Glaucoma Society, industry collaborators at Zeiss and National Institutes of Health funding through the Southern California Clinical and Translational Science Institute. Bolo and his teammates at the USC Roski Eye Institute are using machine learning algorithms to comb through long-term data about current glaucoma screening practices. They aim to bring light to unanswered questions about the effectiveness of current screening in improving patient outcomes.\u201cThere are some gaps in our literature,\u201d Bolo said. \u201cScreening has a long history in glaucoma, but the health outcomes and any potential for unintended effects have never been studied thoroughly. We\u2019re trying to analyze large amounts of data to make conclusions about the practice of screening that can be applied broadly.\u201d","breadcrumb":{"@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/#primaryimage","url":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2026\/05\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg","contentUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2026\/05\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-scaled.jpg","width":2560,"height":1440,"caption":"Kyle Bolo (Photo by Ricardo Carrasco III)"},{"@type":"BreadcrumbList","@id":"https:\/\/keck.usc.edu\/news\/inspired-by-patients-usc-clinician-scientist-kyle-bolo-aims-to-improve-glaucoma-screening\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/keck.usc.edu\/news\/"},{"@type":"ListItem","position":2,"name":"Inspired by patients, USC clinician-scientist Kyle Bolo aims to improve glaucoma screening"}]},{"@type":"WebSite","@id":"https:\/\/keck.usc.edu\/news\/#website","url":"https:\/\/keck.usc.edu\/news\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/keck.usc.edu\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/keck.usc.edu\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/keck.usc.edu\/news\/#organization","name":"Keck School of Medicine of USC","alternateName":"Keck School of Medicine","url":"https:\/\/keck.usc.edu\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/logo\/image\/","url":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/keck-school-of-medicine-logo-696-square.jpg","contentUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/keck-school-of-medicine-logo-696-square.jpg","width":696,"height":696,"caption":"Keck School of Medicine of USC"},"image":{"@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KECKschoolUSC\/","https:\/\/x.com\/KeckSchool_USC","https:\/\/www.linkedin.com\/school\/keckschoolusc\/","https:\/\/www.instagram.com\/KeckSchoolUSC\/","https:\/\/www.youtube.com\/channel\/UCpL1E1W5ZTfkc5iihwLSFEA","https:\/\/www.tiktok.com\/@keckschoolusc"]},{"@type":"Person","@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/person\/6cfb16bad28bfa5e488ddb7cfe47cd3d","name":"lytal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/22ea1d436dde113885aec63d42e72b924f771e6f26d86979609313d84845e184?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/22ea1d436dde113885aec63d42e72b924f771e6f26d86979609313d84845e184?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/22ea1d436dde113885aec63d42e72b924f771e6f26d86979609313d84845e184?s=96&d=mm&r=g","caption":"lytal"},"url":"https:\/\/keck.usc.edu\/news\/author\/clytal\/"}]}},"author_meta":{"display_name":"lytal","author_link":"https:\/\/keck.usc.edu\/news\/author\/clytal\/"},"featured_img":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2026\/05\/Bolo-Kyle-A_MD_Eye_2025_01-by-Ricardo-Carrasco-III-crop-300x169.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/keck.usc.edu\/news\/category\/campus-news\/\" class=\"advgb-post-tax-term\">Campus News<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Campus News<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/keck.usc.edu\/news\/category\/campus-news\/\" class=\"advgb-post-tax-term\">Brain Health<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/campus-news\/\" class=\"advgb-post-tax-term\">Department of Ophthalmology<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/campus-news\/\" class=\"advgb-post-tax-term\">Latest<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/campus-news\/\" class=\"advgb-post-tax-term\">Research<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/campus-news\/\" class=\"advgb-post-tax-term\">USC Roski Eye Institute<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Brain Health<\/span>","<span class=\"advgb-post-tax-term\">Department of Ophthalmology<\/span>","<span class=\"advgb-post-tax-term\">Latest<\/span>","<span class=\"advgb-post-tax-term\">Research<\/span>","<span class=\"advgb-post-tax-term\">USC Roski Eye Institute<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 1 week ago","modified":"Updated 1 week ago"},"absolute_dates":{"created":"Posted on May 18, 2026","modified":"Updated on May 18, 2026"},"absolute_dates_time":{"created":"Posted on May 18, 2026 10:45 am","modified":"Updated on May 18, 2026 10:46 am"},"featured_img_caption":"Kyle Bolo (Photo by Ricardo Carrasco III)","series_order":"","_links":{"self":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/posts\/10191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/users\/176"}],"replies":[{"embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/comments?post=10191"}],"version-history":[{"count":0,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/posts\/10191\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/media\/10193"}],"wp:attachment":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/media?parent=10191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/categories?post=10191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/tags?post=10191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}